Improving Care After Chemotherapy
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer, Lung Cancer, Colorectal Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/16/2015 |
| Start Date: | September 2013 |
| Contact: | Theresa McDonnell, DNP, APRN-BC |
| Email: | tmcdonnell@partners.org |
| Phone: | 617-726-2602 |
The main purpose of this study is to examine changes in patient-reported symptoms during the
first two cycles of neoadjuvant or adjuvant chemotherapy for non-small cell lung cancer
(NSCLC) and colorectal cancer (CRC), among patients who receive standard care plus a
proactive nursing intervention relative to patients who receive standard care alone.
Interventions to improve symptom management and prevent urgent care needs in both the clinic
and hospital for patients receiving chemotherapy with curative intent are needed to enhance
the quality of cancer care.
first two cycles of neoadjuvant or adjuvant chemotherapy for non-small cell lung cancer
(NSCLC) and colorectal cancer (CRC), among patients who receive standard care plus a
proactive nursing intervention relative to patients who receive standard care alone.
Interventions to improve symptom management and prevent urgent care needs in both the clinic
and hospital for patients receiving chemotherapy with curative intent are needed to enhance
the quality of cancer care.
- Participants with NSCLC or CRC undergoing neoadjuvant or adjuvant chemotherapy will be
asked to fill out self-report questionnaires at their first chemotherapy administration
visit, in order to measure patient-reported symptoms, psychological distress, and
satisfaction with oncology care.
- Participants will then be randomized into one of the two study groups: standard care
with proactive phone calls from nurse practitioners or standard care alone.
- Participants assigned to the standard care group will be treated by their care team as
would any other cancer patient.
- Participants assigned to the intervention group will receive four proactive phone calls
from nurse practitioners designed to discuss symptom burden and management. Proactive
phone calls will occur 2-4 days after chemotherapy administration and 5-7 days after
chemotherapy administration, during cycles 1 and 2.
- Participants will be asked to fill out the same set of questionnaires during their
second and third chemotherapy administration visits, to assess patient-reported
symptoms, psychological distress, and satisfaction with oncology care.
- Medical records will be reviewed at 24-weeks following the first chemotherapy
administration visit, to evaluate frequency of urgent outpatient cancer center visits,
emergency department visits, and hospital admissions that occurred during the study
period.
asked to fill out self-report questionnaires at their first chemotherapy administration
visit, in order to measure patient-reported symptoms, psychological distress, and
satisfaction with oncology care.
- Participants will then be randomized into one of the two study groups: standard care
with proactive phone calls from nurse practitioners or standard care alone.
- Participants assigned to the standard care group will be treated by their care team as
would any other cancer patient.
- Participants assigned to the intervention group will receive four proactive phone calls
from nurse practitioners designed to discuss symptom burden and management. Proactive
phone calls will occur 2-4 days after chemotherapy administration and 5-7 days after
chemotherapy administration, during cycles 1 and 2.
- Participants will be asked to fill out the same set of questionnaires during their
second and third chemotherapy administration visits, to assess patient-reported
symptoms, psychological distress, and satisfaction with oncology care.
- Medical records will be reviewed at 24-weeks following the first chemotherapy
administration visit, to evaluate frequency of urgent outpatient cancer center visits,
emergency department visits, and hospital admissions that occurred during the study
period.
Inclusion Criteria:
- Adult (age 18 or older)
- Newly diagnosed stage I-III colorectal cancer or non-small-cell lung cancer
- Scheduled to receive neoadjuvant chemotherapy (i.e. pre-surgical cancer-directed
therapy with curative intent) or adjuvant chemotherapy (i.e. post-surgical
cancer-directed therapy with curative intent)
- Able to respond to questions in English
Exclusion Criteria:
- Already received 1 or more cycles of chemotherapy for the current regimen
- Unwilling or unable to participate in the study
We found this trial at
1
site
Click here to add this to my saved trials
